• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Amazon Makes Bold Move into DTC Healthcare Services

Amazon Makes Bold Move into DTC Healthcare Services

by Glenn S. Demby | Mar 1, 2023 | News

Though the e-commerce giant recently closed its acquisition of One Medical, FTC antitrust intervention could disrupt Amazon’s plans.

FDA Watch: Agency Clears the Way for Approval of Blood-Based PSA Test

FDA Watch: Agency Clears the Way for Approval of Blood-Based PSA Test

by Glenn S. Demby | Dec 3, 2019 | FDA-lir, Industry Buzz-lir, Laboratory Industry Report

The U.S. Preventive Services Task Force (USPTF) recommends that men age 55 to 65 consider prostate cancer screening. The reason it doesn’t directly recommend testing for all men in this age group is that current screening methods that rely on detecting high levels of

This content is for Paid Members only.
Login Register

FDA Watch: Agency Confirms that LOINC Coding of IVD Tests Is Voluntary

by Glenn S. Demby | Aug 1, 2018 | FDA-lir, Industry Buzz-lir, Laboratory Industry Report

...

This content is for Paid Members only.
Login Register
FDA Watch: New Policy Would Allow DTC Marketing of Genetic Tests without Premarket Approval

FDA Watch: New Policy Would Allow DTC Marketing of Genetic Tests without Premarket Approval

by Glenn S. Demby | Dec 4, 2017 | FDA-lir, Industry Buzz-lir, Laboratory Industry Report

From - Laboratory Industry Report
For years, the lab industry has been pressing the FDA to relinquish its rigorous oversight of direct-to-consumer (DTC) genetic health tests…


. . . read more

This content is for Paid Members only.
Login Register

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com